Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armanda Casrouge

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Microbes and Infection|September 24, 2004
The human and mouse orthologous LIM-only proteins respectively encoded in chromosome 6 and 17 show a different expression patternArmanda Casrouge, Reiner Veitia, Jacqueline Kirchner, et al.
Plos One|July 17, 2015
Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free TherapyEric G Meissner, Jérémie Decalf, Armanda Casrouge, et al.
Scientific Reports|May 23, 2024
Absence of sympathetic innervation hampers the generation of tertiary lymphoid structures upon acute lung inflammationClémence Riffard, Laïla Letaïef, Safa Azar, et al.
Hepatology (Baltimore, Md.)|March 27, 2014
Truncated CXCL10 is associated with failure to achieve spontaneous clearance of acute hepatitis C infectionAntonio Riva, Melissa Laird, Armanda Casrouge, et al.
Clinical Immunology (Orlando, Fla.)|January 14, 2014
Low DPP4 expression and activity in multiple sclerosisMarta Tejera-Alhambra, Armanda Casrouge, Clara de Andrés, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Interferon induced protein 10 remains a useful biomarker of treatment failure in patients stratified for the interleukin-28B rs12979860 haplotypeMatthew L Albert, Armanda Casrouge, Stéphane Chevaliez, et al.
EMBO Molecular Medicine|May 4, 2016
Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post-translational modification: prospective placebo-controlled clinical studiesJérémie Decalf, Kristin V Tarbell, Armanda Casrouge, et al.
The Journal of Clinical Investigation|December 25, 2010
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCVArmanda Casrouge, Jérémie Decalf, Mina Ahloulay, et al.
Plos One|June 4, 2015
Plasma biomarkers discriminate clinical forms of multiple sclerosisMarta Tejera-Alhambra, Armanda Casrouge, Clara de Andrés, et al.
Blood|February 14, 2022
Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC-transplanted SCID patients with IL2RG/JAK3 deficiencyPedro Goncalves, Jean-Marc Doisne, Toshiki Eri, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Microbes and Infection|September 24, 2004
The human and mouse orthologous LIM-only proteins respectively encoded in chromosome 6 and 17 show a different expression patternArmanda Casrouge, Reiner Veitia, Jacqueline Kirchner, et al.
Plos One|July 17, 2015
Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free TherapyEric G Meissner, Jérémie Decalf, Armanda Casrouge, et al.
Scientific Reports|May 23, 2024
Absence of sympathetic innervation hampers the generation of tertiary lymphoid structures upon acute lung inflammationClémence Riffard, Laïla Letaïef, Safa Azar, et al.
Hepatology (Baltimore, Md.)|March 27, 2014
Truncated CXCL10 is associated with failure to achieve spontaneous clearance of acute hepatitis C infectionAntonio Riva, Melissa Laird, Armanda Casrouge, et al.
Clinical Immunology (Orlando, Fla.)|January 14, 2014
Low DPP4 expression and activity in multiple sclerosisMarta Tejera-Alhambra, Armanda Casrouge, Clara de Andrés, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Interferon induced protein 10 remains a useful biomarker of treatment failure in patients stratified for the interleukin-28B rs12979860 haplotypeMatthew L Albert, Armanda Casrouge, Stéphane Chevaliez, et al.
EMBO Molecular Medicine|May 4, 2016
Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post-translational modification: prospective placebo-controlled clinical studiesJérémie Decalf, Kristin V Tarbell, Armanda Casrouge, et al.
The Journal of Clinical Investigation|December 25, 2010
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCVArmanda Casrouge, Jérémie Decalf, Mina Ahloulay, et al.
Plos One|June 4, 2015
Plasma biomarkers discriminate clinical forms of multiple sclerosisMarta Tejera-Alhambra, Armanda Casrouge, Clara de Andrés, et al.
Blood|February 14, 2022
Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC-transplanted SCID patients with IL2RG/JAK3 deficiencyPedro Goncalves, Jean-Marc Doisne, Toshiki Eri, et al.
Pageof 3